Survivin,
a well-known member of the inhibitor of apoptosis protein
family, is upregulated in many cancer cells, which is associated with
resistance to chemotherapy. To circumvent this, inhibitors are currently
being developed to interfere with the nuclear export of survivin by
targeting its protein–protein interaction (PPI) with the export
receptor CRM1. Here, we combine for the first time a supramolecular
tweezer motif, sequence-defined macromolecular scaffolds, and ultrasmall
Au nanoparticles (us-AuNPs) to tailor a high avidity inhibitor targeting
the survivin-CRM1 interaction. A series of biophysical and biochemical
experiments, including surface plasmon resonance measurements and
their multivalent evaluation by EVILFIT, reveal that for divalent
macromolecular constructs with increasing linker distance, the longest
linkers show superior affinity, slower dissociation, as well as more
efficient PPI inhibition. As a drawback, these macromolecular tweezer
conjugates do not enter cells, a critical feature for potential applications.
The problem is solved by immobilizing the tweezer conjugates onto
us-AuNPs, which enables efficient transport into HeLa cells. On the
nanoparticles, the tweezer valency rises from 2 to 16 and produces
a 100-fold avidity increase. The hierarchical combination of different
scaffolds and controlled multivalent presentation of supramolecular
binders was the key to the development of highly efficient survivin-CRM1
competitors. This concept may also be useful for other PPIs.